Calorify Bolsters Commercialization of Doubly Labeled Water Test by Welcoming Clinical, Obesity and Diabetes Expert Dr. Justin Ryder to Its Advisory Board
July 16 2024 - 8:00AM
Business Wire
Calorify, the producer of the world's most accurate measure of
energy expenditure, today announced the appointment of Justin
Ryder, Ph.D., as a Clinical Research Advisor to support the company
as it commercializes and further innovates its doubly labeled water
(DLW) metabolic rate test. Calorify’s DLW test is a transformative
measure of energy expenditure that could help uncover data-driven
treatments for common, life-threatening metabolic diseases, such as
obesity and diabetes.
Dr. Ryder holds appointments at Northwestern and Lurie
Children’s Hospital. For the last three years, Dr. Ryder relied on
data from DLW tests to ensure his clinical trials included the most
accurate metabolism and expenditure data. He is currently working
with the National Institutes of Health (NIH) on obesity trials. At
Calorify, Dr. Ryder will advise on research and development,
evaluating and implementing customer feedback, market needs and the
latest clinical trial trends for Calorify’s DLW offering.
Calorify’s customers - ranging from pharmaceutical and biotech
companies to sports/athletic companies to researchers across
various industries - will benefit from Dr. Ryder’s scientific
expertise of DLW in the clinical trial space.
“As an obesity scientist, I fully understand the importance and
value of better metabolic rate testing and the impact it can have
on fighting obesity,” said Dr. Justin Ryder, vice chair of research
for the Department of Surgery, Lurie Children's Hospital and
associate professor of Surgery and Pediatrics, Northwestern
University Feinberg School of Medicine. “Information is not only
power – in this case, it’s better healthcare decision-making.
Calorify’s breakthrough in DLW testing enables DLW to be used in
clinical trials, and directly by healthcare professionals, to
provide accurate, accessible assessments of metabolism and energy
expenditure.”
“This is a year of big growth for Calorify - from partnerships
to fundraising to adding to our team of experts - all in an effort
to help guide researchers with more accurate metabolic input and
output data, made possible by doubly labeled water. Dr. Ryder will
be a valuable asset to the Calorify team as we build partnerships
across the healthcare spectrum,” said Hari Mix, chief executive
officer and founder, Calorify. “Dr. Ryder is a phenomenal scientist
with an impressive portfolio of work in physiology and medicine. He
will play a pivotal role at Calorify as we continue to serve our
pharmaceutical, biotech and research customers.”
About Calorify
Calorify is the first lab to commercialize precise metabolic
rate measurements using the doubly labeled water method. While the
science has existed for over 40 years, tests were limited to those
participating in academic research. Calorify’s lab quantitatively
measures how much CO₂ an individual produces to measure calories in
a real-world setting. It aims to democratize one of the most
critical data points about the human body. Calorify's focus has
been on reducing the cost of DLW to make it more available to
academic institutions, biotechnology companies, and pharmaceutical
companies. With its customizable protocol, Calorify’s high
throughput lab can deliver quality results quickly to institutional
clients.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240716058892/en/
Media Inquiries: Mitti Bose Kalra SVP, Biotech & Life
Sciences PR Lead Makovsky mkalra@makovsky.com Business
Inquiries: Karl Etzel VP, Business Development Calorify
karl@calorify.com